Form 4: ATAI Life Sciences Executive Sahil Kirpekar Sells Shares to Cover Tax Obligations

Sahil Kirpekar, Chief Business Officer of ATAI Life Sciences N.V., sold 35,801 common shares on April 2, 2024, to cover tax liabilities arising from the vesting of restricted stock units.

Summary

• On April 2, 2024, Sahil Kirpekar, the Chief Business Officer of ATAI Life Sciences N.V., sold 35,801 common shares of the company.
• The shares were sold at a price of $1.85 per share.
• The sale was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Kirpekar directly owns 64,199 common shares of ATAI Life Sciences N.V.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by a company executive, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. Often these sales are to cover tax obligations.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment.

Key Dates